Dallas, Texas, United States
Welcome to Your TIL Speaker
An official site by Chris White of Mucosal Melanoma Survivor, LLC for Speaking Inquiries and Engagements.
About "Your TIL Speaker"
Self-Published Author of "Killing Cancer With TILs"
I AM the last patient dosed in the phase 2, cohort 4 clinical trial for the 1st ever, FDA approved, Advanced Cellular Therapy for any Solid Tumor cancer in history.
You may recognize it as Lifileucel or its commercial name, AMTAGVI. I am the last 1 of the 153 total patients dosed in my trial, I am 1 of the 12 Mucosal Melanoma patients as well as 1 of the 6 from those 12 to have yielded a response. A phenomenal miracle considering I was stage 4 with metastasis to all major organs, my brain, and had failed on every possible treatment that existed at the time.
After receiving my TILs infusion on January 15, 2020, I had all 6 recommended doses of IL-2 and that was the last treatment I ever did. Within 6 weeks I had a 50-60% reduction and within 9 months, my scans showed I had a CMR or Complete Metabolic Response. Even though the approval of this therapy is a 2nd line of treatment for unresectable late-stage melanoma, it's accelerated approval in February 2024 made its mark in history and opened the door for more Biotherapeutics and advanced cellular therapies in solid tumor cancers.
Since 90% of all cancer diagnosis are of solid tumors and current statistic state that 40% of all people will at some point in their lifetime be affected by cancer, knowing that there are options, that preserve quality with quantity is more than half the battle.
Host and Creator of TIL Talks Podcast
TIL Talks is dedicated to educating and bringing awareness to TILs and ALL CELL & GENE Therapies. Aimed to reach ALL demographics, ages, and on multiple platforms, this program provides direct one-on-one conversations with patient recipients, caregivers, and industry leaders who have borne witness to the curative abilities of these novel modalities 1st hand. No matter what the diagnoses of a patient, the goal is always to eradicate and rid the disease while also preserving quality of life. Problem is, most people don't know to ask because they don't know they exist. That's all about to change
My Approach to Speaking
As an Independent Contract Consultant and founder of Mucosal Melanoma Survivor LLC, my approach is simple. Be authentic and organic in everything I do and speak from the heart. Life is all trial and error and sometimes you just figure it out as you go but when you find your passion, your purpose, it's meaningful and you do it no matter what.
My Mission as a Clinical Trial Participant and TIL Therapy Recipient
My Mission is to pay it forward as a Beacon of Hope to both the Patient/Caregiver Community as well as the Biotherapeutics/Medical/Clinical/Oncology, and Life Sciences Industries. I'm very proud and passionate when it comes to sharing my experience as a TIL Therapy recipient and participating in a Clinical Trial. I aim to inspire,
A Transformation both personally and professionally
From diagnosis until last treatment was about 18 months. After trying everything available and only one option left, Chris went for his last at bat. One last shot in a Clinical Trial for TIL Therapy. He didn’t just hit a home run, he hit a grand slam out the park at the bottom of the 9th for the win. After the dust had all settled, Chris founded Mucosal Melanoma Survivor, LLC in March of 2023.
5 out of 5 stars Book Reviews for "Killing Cancer with TILs"
Insightful and informative book on dealing with a rare cancer Reviewed in the U.S. on May 21, 2024
In 'Killing Cancer with TILs,' Chris White shares his compelling journey of battling a rare and aggressive cancer in his mid-30s. From early symptoms to diagnosis and various treatments with severe side effects, Chris's story culminates in his participation in an experimental TIL therapy clinical trial that saved his life. Alongside medical insights, he reflects on the personal struggles, work-life balance, family support, and mental challenges he faced.
As a cancer researcher familiar with treatments and trials, I found this book enlightening for understanding the patient's perspective. Having met Chris recently, his passion and personality shine through in his storytelling.
I highly recommend this book—it's a must-read for anyone interested in the personal impacts of cancer
Chris White shares the raw story of the hardest part of his life Review on April 25, 2024
We were honored to interview the author last year. Our weekly show helps rare and chronically ill guests share their health care stories. I was so glad to see he got his memoir published and ordered it immediately! What an amazing book that shows the power and perseverance of a young man with a cancer diagnosis. When many people might have given up hope, Chris kept fighting for his life. I hope and pray he can stay healthy now that he successfully kicked cancer’s butt! (Oops! Did I give away the ending?) I highly recommend this book.
Recommend Reviewed in the United States on April 17, 2024
This book was inspirational, interesting, and so enjoyable to read. I read it in a short amount of time because I didn't want to put it down. You feel like you are going through the journey with Chris. He writes very clearly and tells the story exactly how it was.
AMAZING STORY Reviewed in the United States on April 10, 2024
This book brings to light the many battles cancer patients face, it's so raw and relatable in so many ways. So powerful and uplifting and honest. Thank you for writing this book and sharing your story of hope!!!
Inspiring Change with Your Til Speaker
Review from Adrienne B. Mendoza, MHA-SVP BioBridge Global and Chief Operating Officer (COO), BBG Adv
It is my privilege to recommend Chris White for his exceptional work as an advocate and inspiration in the field of health care and cell and gene therapies. Chris has not only triumphed over his own battle with cancer through TIL therapy, but he has also turned his journey into a source of hope and motivation for others.
At our annual company engagement event, Chris shared his powerful story, bringing us into the deeply personal and challenging road he navigated. His resilience, courage, and willingness to be a voice for patients make a profound impact on those working in cell and gene therapy. He reminds us why our work matters - because behind every scientific breakthrough, there is a person fighting for their life.
Chris’s advocacy extends beyond his own experience. Through his efforts to educate and inspire, he continues to drive awareness of cutting-edge treatments like TIL therapy. His ability to connect with audiences, whether patients, caregivers, or professionals in the field, comes from his dedication and authenticity.
I wholeheartedly recommend Chris as a speaker, advocate, and leader in patient-centered innovation. His story is a call to action for all of us in health care to keep pushing the boundaries of what’s possible in the fight against cancer.
Inspiring Change with Your Til Speaker
Review from Stephanie Kaufman-President & COO Melanoma Research Alliance-February 27, 2024
I have had the great pleasure of seeing the power of Chris White in action in humanizing cancer research to an audience. He is an exceptional storyteller and speaker in the realm of rare melanomas and most specifically mucosal melanoma. His ability to captivate an audience with compelling narratives about this critical public health issue is truly remarkable.
Chris possesses a talent for not only educating others about rare melanomas, clinical trials and the patient voice, but also instilling a sense of urgency and empathy to each audience he engages with. Chris also has a distinct insight to the first cellular therapy, known as TIL therapy, that has been approved by the FDA. He is a key patient opinion leader on his experiences with TIL therapy and its promise for the melanoma community.
I highly recommend Chris to any organization or event looking for a speaker who can effectively communicate the importance of cancer research, patient advocacy, demystifying clinical trials and new horizons in melanoma research through his lens as a rare melanoma thriver.